Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.

about

Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma.

P2860

Q37028654-EDCAC5CD-3BF1-4A63-A534-99B2E0954E1D Q38770085-67E2A92B-446A-4F1B-93DD-28A8233457EB

P2860

Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.

Item

http://www.wikidata.org/entity/Q36784375

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intracranial AAV-sTRAIL combin ...... odel of invasive glioblastoma.

@en

type

Item

label

Intracranial AAV-sTRAIL combin ...... odel of invasive glioblastoma.

@en

prefLabel

Intracranial AAV-sTRAIL combin ...... odel of invasive glioblastoma.

@en

P1476

Intracranial AAV-sTRAIL combin ...... odel of invasive glioblastoma.

@en

P2093

Bakhos A Tannous

http://www.w3.org/2001/XMLSchema#string

Casey A Maguire

http://www.w3.org/2001/XMLSchema#string

Christian E Badr

http://www.w3.org/2001/XMLSchema#string

Johanna M Niers

http://www.w3.org/2001/XMLSchema#string

Thomas Würdinger

http://www.w3.org/2001/XMLSchema#string

W Peter Vandertop

http://www.w3.org/2001/XMLSchema#string

P2860

The receptor for the cytotoxic ligand TRAIL

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

Preventing growth of brain tumors by creating a zone of resistance.

Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells.

mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells

Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain.

Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform.

Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.

P304

625-634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLONC.2015.11.011

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matheus H W Crommentuijn

P577

2015-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26708508

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

4826802

http://www.w3.org/2001/XMLSchema#string

Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.

about

P2860

P2860

Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932